DENGUE

IDE 20.3 Climate Change and Public Health

REMINDERS!!
Long Quiz:
February 29, 2024 (EB3)
March 1, 2024 (EB1)
Reporting
March 7, 2024 (EB3)
March 8, 2024 (EB1)
Midterm Examination Coverage
March 18-23, 2024
Chapters 10-15
DENGUE
is a mosquito-borne disease
transmitted by the urban dwelling
mosquito Aedes aegypti and
cold-tolerant species Aedes
albopictus
Have asymptomatic to life
threatening symptoms.
Primary source of
transmission: HUMANS
SYMPTOMS
Symptoms may includes: High
fever, headache, pain behind the
eyes, nausea, vomiting, swollen
glands and rashes
TRANSMISSION AND GLOBAL EXPANSION
Incidence of dengue has increased dramatically in many
countries.
Occuring in new areas and re-emerging in others
increases in poor and urban populations
increased travel and trade
environmental disturbances
break-down in public health measures
reduced population immunity
RISK FACTORS OF DENGUE

Geographical location
people in areas infested with Aedes mosquitos.
Age
children are at high risk of severe dengue.
repeated infections can increase the severity.
Immune Status
Individual with compromised immune system
Prior infection
DENGUE PREVENTION
Mosquito control
reduce mosquito breeding and exposure.
Vector control
Community-based efforts to control mosquito populations.
Protective clothing
Wearing long sleeves, pants, and mosquito nets can reduce
the risk of mosquito bites.
Vaccination
Vaccination program reduce the risk for certain individuals